BostonSight
Laurel Villers is an accomplished professional with extensive experience in business development and sales strategy within the healthcare sector. Currently serving as the Chief Business Development Officer at BostonSight since December 2019, Laurel focuses on advancing the treatment and care of complex corneal diseases. Prior to this role, Laurel held various leadership positions at Aptus Health from October 2014 to December 2019, including Vice President of Global Sales Strategy and Operations. Additional experience includes roles at Quantia Inc. (Director, Client Services), Phreesia (Sales Director), InfoMedics (VP, US Pharma Sales), Nortel Networks (Program Director, Usability Design Group), and BC Research Inc. (Director, Ergonomics and Human Factors Group). Laurel earned both a Master’s and a Bachelor’s degree in Kinesiology from Simon Fraser University, with studies spanning from 1989 to 1997.
This person is not in any teams
BostonSight
BostonSight is a nonprofit healthcare organization that advances the treatment of diseased and damaged corneas and dry eye. We work toward optimal patient outcomes through compassionate care, innovative scleral lens design, education, and technology. PROSE® is our medical treatment for the most severe or challenging ocular surface disease cases and delivered via highly trained eye care professionals at top tertiary eye centers. BostonSight SCLERAL® is our commercially available scleral lens used by optometrists worldwide. BostonSight SCLERAL provides diagnostic lens and free form fitting options with a range of diameters and features to simplify scleral lens fitting. BostonSight SCLERAL is effective for simple to more advanced ocular surface disease cases. Learn more at www.bostonsight.org and www.bostonsightscleral.org